Unilever (ULVR) Stock Soars 6.8% Following Stellar Q2 Performance and Upgraded Guidance

Key Highlights

Table of Contents

Shares of Unilever climbed more than 6% in London trading following second-quarter underlying sales expansion of 5.8%, significantly exceeding the 4.3% analyst projection
The company achieved 5.5% volume expansion, marking its most impressive quarterly volume performance in more than ten years
Management elevated its full-year guidance to 4%-6% underlying sales growth from previously targeting the lower end of this spectrum
The Home Care division topped all segments with 9.1% expansion; the Foods category struggled with merely 0.2% growth
The anticipated merger of Unilever’s Foods division with McCormick continues progressing toward its mid-2027 completion target

Shares of Unilever (ULVR) surged as high as 6.8% to reach £49.43 during Tuesday’s early London session, touching levels not seen since March 6, following the consumer goods giant’s announcement of better-than-anticipated second-quarter figures and an elevated full-year sales projection.

Unilever PLC, UL

By mid-morning, the shares were trading 5.8% higher at £48.96, positioning the stock for its strongest single-session performance in the past two years. This rally follows a 16% decline since tensions related to the Iran conflict began.

The company reported underlying sales expansion of 5.8% during the second quarter, substantially outpacing the 4.3% consensus among market analysts. Revenue reached €13.0 billion, representing a 3.8% increase, even as currency fluctuations created a 2.4% headwind.

UNILEVER RAISES OUTLOOK AS VOLUME GROWTH REACHES 16-YEAR HIGH$UL, Underlying sales grew 5.8%, up from 3.1% a year earlier and above company-compiled estimates. The increase was driven primarily by higher volumes, while pricing contributed just 0.2%.
Beauty and wellbeing sales… pic.twitter.com/EqU76Iqary
— Wall St Engine (@wallstengine) July 28, 2026

The headline figure was the 5.5% volume expansion. This marked the company’s most robust volume performance in any quarter spanning more than a decade, fueled by strong demand across India, Indonesia, and Latin American territories.

Management now anticipates full-year underlying sales growth landing within its 4%-6% multi-year target corridor, an upgrade from previous guidance suggesting performance toward the lower boundary. The company also lifted its volume growth projection to approximately 3%, up from the earlier expectation of at least 2%.

Looking toward the second half of the year, Unilever forecasts 4%-5% sales expansion, primarily driven by pricing actions. The company reaffirmed its expectation for a modest enhancement in full-year underlying operating margin compared to the 20% achieved in 2025.

Core Portfolio Leads Performance

Unilever’s Power Brands portfolio, representing 78% of overall revenue, generated 6% underlying sales growth during the first six months. This collection encompasses well-known names including Axe, Vaseline, Dove, and Cif.

Marketing expenditure represented 16.1% of turnover in the second quarter, with increased investment linked to FIFA World Cup sponsorship activities. CFO Srinivas Phatak emphasized to investors during the earnings call: “The days of underinvesting in our businesses are over.”

The Home Care segment emerged as the strongest performer, delivering 9.1% underlying sales expansion. Beauty & Wellbeing advanced 8.1%, while Personal Care contributed 5.9% growth.

The Foods division represented a notable underperformer. Sales growth registered just 0.2%, constrained by weakness across developed markets and intensifying competitive pressure in the U.S. condiments category. Volume performance within Foods actually declined 0.1%.

McCormick Transaction Progressing as Planned

The company is currently executing the separation of its Foods business, which will merge with American spice producer McCormick to create a combined entity valued at approximately $65 billion. The transaction is projected to finalize no later than mid-2027.

Barclays analyst Warren Ackerman characterized the results as “further evidence that Unilever’s home and personal care portfolio can deliver growth well above many global staples peers,” noting that confidence surrounding post-transaction growth continues building.

Morgan Stanley described the quarterly performance as an unambiguous “beat and raise,” highlighting that the 5.5% volume expansion exceeded expectations by more than double. The firm noted that gross margin experienced some compression due to commodity cost inflation.

Bernstein analyst Callum Elliott suggested the better-than-expected figures “seem likely to drive a significant uptick in positivity today.”